Refine Search
(16)
(19)
(19)
(19)

Oncology

According to World Health Organization (WHO), cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer.

NEW Meningioma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Meningioma - Pipeline Review, H1 2018’, provides an overview of the Meningioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Meningioma, complete wit...

NEW Cervical Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2018’, provides an overview of the Cervical Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cervical Cance...

Head And Neck Cancer - Pipeline Review, H1 2018

  • $2,500
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2018’, provides an overview of the Head And Neck Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Head...

Gastric Cancer - Pipeline Review, H1 2018

  • $2,500
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2018’, provides an overview of the Gastric Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastric Cancer, ...

Peritoneal Cancer - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2018’, provides an overview of the Peritoneal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peritoneal...

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018’, provides an overview of the Human Papillomavirus (HPV) Associated Cancer pipeline landscape.

The report provides comprehensive informatio...

Uveal Melanoma - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H1 2018’, provides an overview of the Uveal Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, ...

Fallopian Tube Cancer - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2018’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fa...

Ureter Cancer - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H1 2018’, provides an overview of the Ureter Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ureter Cancer, com...

Bone Metastasis - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H1 2018’, provides an overview of the Bone Metastasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Metastasi...

Retinoblastoma - Pipeline Review, H1 2018

  • $2,000
  • April 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H1 2018’, provides an overview of the Retinoblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Retinoblastoma, ...

Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2018’, provides an overview of the Cancer Anorexia-Cachexia Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Esophageal Cancer - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2018’, provides an overview of the Esophageal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Esophageal...

Malignant Mesothelioma - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2018’, provides an overview of the Malignant Mesothelioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2018

  • $2,000
  • March 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2018’, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) pipeline landscape.

The report provides comprehensive informat...